Tamoxifen Citrate Tablets

Product Description

Tamoxifen Tablet Uses

Tamoxifen Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:

         -Metastatic Breast Cancer

         -Adjuvant Treatment Of Breast Cancer

Tamoxifen Tablet - Composition and Active Ingredients

Tamoxifen Tablet is composed of the following active ingredients (salts)

         -Tamoxifen Citrate

Please note that this medicine may be available in various strengths for each active ingredient listed above.

Tamoxifen Tablet - Side-effects

The following is a list of possible side-effects that may occur from all constituting ingredients of Tamoxifen Tablet. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.

         -Flush

         -Edema

         -Amenorrhea

         -Fatigue

        -Altered Menses

        -Musculoskeletal Pain

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

North & South America: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, etc .

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.